Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Wnt signaling pathway pharmacogenetics in non-small cell lung cancer.

Stewart DJ, Chang DW, Ye Y, Spitz M, Lu C, Shu X, Wampfler JA, Marks RS, Garces YI, Yang P, Wu X.

Pharmacogenomics J. 2014 Dec;14(6):509-22. doi: 10.1038/tpj.2014.21. Epub 2014 Jul 1.

2.

Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients.

Coscio A, Chang DW, Roth JA, Ye Y, Gu J, Yang P, Wu X.

Carcinogenesis. 2014 Jun;35(6):1284-91. doi: 10.1093/carcin/bgu034. Epub 2014 Feb 11.

3.

Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.

Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, Lu C, Chang JY, Lippman SM, Hong WK, Spitz MR, Romkes M, Yang P.

J Natl Cancer Inst. 2011 May 18;103(10):817-25. doi: 10.1093/jnci/djr075. Epub 2011 Apr 11.

4.

Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.

Kim SH, Lee GW, Lee MJ, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim IS, Lee S, Oh SY.

Lung Cancer. 2012 Sep;77(3):578-84. doi: 10.1016/j.lungcan.2012.04.016. Epub 2012 May 18.

PMID:
22608006
5.

Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Chen X, Sun H, Ren S, Kim Curran V, Zhang L, Zhou S, Zhang J, Zhou C.

Clin Transl Oncol. 2012 Mar;14(3):207-13.

PMID:
22374424
6.

Wnt signaling pathway in non-small cell lung cancer.

Stewart DJ.

J Natl Cancer Inst. 2014 Jan;106(1):djt356. doi: 10.1093/jnci/djt356. Epub 2013 Dec 5. Review.

PMID:
24309006
7.

ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients.

Cuffe S, Azad AK, Qiu X, Qiu X, Brhane Y, Kuang Q, Marsh S, Savas S, Chen Z, Cheng D, Leighl NB, Goss G, Laurie SA, Seymour L, Bradbury PA, Shepherd FA, Tsao MS, Chen BE, Xu W, Liu G.

Cancer Epidemiol. 2016 Apr;41:50-6. doi: 10.1016/j.canep.2015.12.012. Epub 2016 Jan 24.

PMID:
26816351
8.

Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients.

Vasile E, Tibaldi C, Leon GL, D'Incecco A, Giovannetti E.

J Cancer Res Clin Oncol. 2015 Jul;141(7):1189-94. doi: 10.1007/s00432-014-1880-3. Epub 2014 Dec 14.

PMID:
25504507
9.

Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.

Lin M, Stewart DJ, Spitz MR, Hildebrandt MA, Lu C, Lin J, Gu J, Huang M, Lippman SM, Wu X.

Carcinogenesis. 2011 Jul;32(7):1050-6. doi: 10.1093/carcin/bgr067. Epub 2011 Apr 22.

10.

Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.

Du Y, Su T, Zhao L, Tan X, Chang W, Zhang H, Cao G.

PLoS One. 2014 Jun 16;9(6):e99843. doi: 10.1371/journal.pone.0099843. eCollection 2014.

11.

Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer.

Yin J, Lu C, Gu J, Lippman SM, Hildebrandt MA, Lin J, Stewart D, Spitz MR, Wu X.

Carcinogenesis. 2011 Dec;32(12):1867-71. doi: 10.1093/carcin/bgr217. Epub 2011 Sep 28.

12.

Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.

Guo X, Li D, Wu Y, Chen Y, Zhou X, Wang X, Huang X, Li X, Yang H, Xing J.

Lung Cancer. 2015 Feb;87(2):162-8. doi: 10.1016/j.lungcan.2014.12.005. Epub 2014 Dec 18.

PMID:
25576295
14.

Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy.

Ren S, Zhou S, Wu F, Zhang L, Li X, Zhang J, Xu J, Lv M, Zhang J, Zhou C.

Lung Cancer. 2012 Jan;75(1):102-9. doi: 10.1016/j.lungcan.2011.05.023. Epub 2011 Jun 14.

PMID:
21676483
15.

Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.

Tan M, Wu J, Cai Y.

Biochem Biophys Res Commun. 2013 Sep 6;438(4):673-9. doi: 10.1016/j.bbrc.2013.07.123. Epub 2013 Aug 9.

PMID:
23939044
16.

Effect of nitric oxide synthase on multiple drug resistance is related to Wnt signaling in non-small cell lung cancer.

Li Y, Ma C, Shi X, Wen Z, Li D, Sun M, Ding H.

Oncol Rep. 2014 Oct;32(4):1703-8. doi: 10.3892/or.2014.3351. Epub 2014 Jul 23.

PMID:
25070480
17.

Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Sullivan I, Salazar J, Majem M, Pallarés C, Del Río E, Páez D, Baiget M, Barnadas A.

Cancer Lett. 2014 Oct 28;353(2):160-6. doi: 10.1016/j.canlet.2014.07.023. Epub 2014 Jul 25.

PMID:
25069034
18.

Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.

Miao Y, Wang L, Zhang X, Xu X, Jiang G, Fan C, Liu Y, Lin X, Yu J, Zhang Y, Wang E.

PLoS One. 2014 Nov 14;9(11):e112258. doi: 10.1371/journal.pone.0112258. eCollection 2014.

19.

Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.

Tan X, Wu Q, Cai Y, Zhao X, Wang S, Gao Z, Yang Y, Li X, Qian J, Wang J, Su B, Chen H, Han B, Jiang G, Lu D.

Clin Lung Cancer. 2014 Jan;15(1):67-78.e12. doi: 10.1016/j.cllc.2013.08.006. Epub 2013 Nov 9.

PMID:
24220096
20.

DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy.

Wang LE, Yin M, Dong Q, Stewart DJ, Merriman KW, Amos CI, Spitz MR, Wei Q.

J Clin Oncol. 2011 Nov 1;29(31):4121-8. doi: 10.1200/JCO.2010.34.3616. Epub 2011 Sep 26.

Supplemental Content

Support Center